Search research articles
Contact Us
Filters
Showing results (121-130 of 678) with videos related to
Page
of 68
Sort By:
Brain Research Bulletin
|
July 1, 1982
Two-color immunohistochemistry for dopamine and GABA neurons in rat substantia nigra and zona incerta
W H Oertel, M L Tappaz, A Berod, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 25, 2009
Treatment of hypersexuality in Parkinson's disease with carbamazepine--a case report
Jan-Philipp Bach, Wolfgang H Oertel, Richard Dodel, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1995
Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995
A Kupsch, W H Oertel, C D Earl, et al.
Nuclear Medicine Communications
|
August 1, 1991
SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease
K Tatsch, J Schwarz, W H Oertel, et al.
Experimental Brain Research
|
January 10, 1998
Degeneration of pre-labelled nigral neurons induced by intrastriatal 6-hydroxydopamine in the rat: behavioural and biochemical changes and pretreatment with the calcium-entry blocker nimodipine
J Sautter, A Kupsch, C D Earl, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 7, 1998
[Recommendations for the indications for growth hormone substitution in adult age groups. Working group for pituitary gland and pituitary tumors of the German Society for Endocrinology]
H Oertel, C J Strasburger, P Kann, et al.
Archives Italiennes De Biologie
|
June 1, 1984
Immunocytochemical identification of GABAergic neurons in the main olfactory bulb of the rat
E Mugnaini, F G Wouterlood, A L Dahl, et al.
MMW Fortschritte Der Medizin
|
August 30, 2007
[Advances in the treatment of multiple sclerosis?]
B Tackenberg, H Himmerich, A Wellek, et al.
MMW Fortschritte Der Medizin
|
August 6, 2008
[Myasthenia gravis--diagnosis, therapy and special problems]
B Tackenberg, K Gellert, J Kruth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 17, 1997
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy
J Schwarz, K Tatsch, T Gasser, et al.
Page
of 68
Search research articles
Search
Showing results (121-130 of 678) with videos related to
Sort By:
Page
of 68
Brain Research Bulletin
|
July 1, 1982
Two-color immunohistochemistry for dopamine and GABA neurons in rat substantia nigra and zona incerta
W H Oertel, M L Tappaz, A Berod, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 25, 2009
Treatment of hypersexuality in Parkinson's disease with carbamazepine--a case report
Jan-Philipp Bach, Wolfgang H Oertel, Richard Dodel, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1995
Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995
A Kupsch, W H Oertel, C D Earl, et al.
Nuclear Medicine Communications
|
August 1, 1991
SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease
K Tatsch, J Schwarz, W H Oertel, et al.
Experimental Brain Research
|
January 10, 1998
Degeneration of pre-labelled nigral neurons induced by intrastriatal 6-hydroxydopamine in the rat: behavioural and biochemical changes and pretreatment with the calcium-entry blocker nimodipine
J Sautter, A Kupsch, C D Earl, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 7, 1998
[Recommendations for the indications for growth hormone substitution in adult age groups. Working group for pituitary gland and pituitary tumors of the German Society for Endocrinology]
H Oertel, C J Strasburger, P Kann, et al.
Archives Italiennes De Biologie
|
June 1, 1984
Immunocytochemical identification of GABAergic neurons in the main olfactory bulb of the rat
E Mugnaini, F G Wouterlood, A L Dahl, et al.
MMW Fortschritte Der Medizin
|
August 30, 2007
[Advances in the treatment of multiple sclerosis?]
B Tackenberg, H Himmerich, A Wellek, et al.
MMW Fortschritte Der Medizin
|
August 6, 2008
[Myasthenia gravis--diagnosis, therapy and special problems]
B Tackenberg, K Gellert, J Kruth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 17, 1997
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy
J Schwarz, K Tatsch, T Gasser, et al.
Page
of 68